Strikingly, tumor-infiltrating cDC2s exhibited higher levels of Dectin-1, DC-SIGN, DEC-205 or CD206 (in frequencies and/or intensity) when compared to control tissue (Figure 1D; Supplementary Figure 3C). The gene discussed is CD209; the disease is neoplasm.